Efficacy of ceftazidime-avibactam in the treatment of infections due to Carbapenem-resistant Enterobacteriaceae.

Basem M AlraddadiMohammed SaeediMohammed QutubAbeer AlshukairiAshraf HassanienGhassan Wali

Published in: BMC infectious diseases (2019)

In patients with established OXA-48-type CRE infection, CAZ-AVI is a reasonable alternative to standard therapy. These findings need to be confirmed in prospective studies.

Keyphrases

klebsiella pneumoniae
multidrug resistant
gram negative
pseudomonas aeruginosa
escherichia coli
acinetobacter baumannii
bone marrow
combination therapy
cystic fibrosis
smoking cessation